Erin Sullivan

Erin Sullivan's work experience includes various roles in the field of health economics and outcomes research. Erin is currently the Vice President of Global Health Economics and Outcomes Research & Real World Evidence at Blueprint Medicines since August 2021. Prior to that, they held the position of Head of Health Economics and Outcomes Research at Blueprint Medicines from September 2019 to August 2021.

Before joining Blueprint Medicines, Erin served as the Vice President of Health Economics & Outcomes Research at Avalere Health from June 2009 to September 2019. Erin also worked as the Senior Director of Health Economics & Reimbursement at Abt Bio-Pharma Solutions, a healthcare consulting firm, in 2008-2009. Erin gained experience at Boston Scientific Corporation as the Director of Health Economics & Reimbursement from 2001 to 2008. Erin'searly career included a role as a Senior Associate at Covance from 1996 to 2000.

Erin Sullivan holds a PhD in Health Policy from The Johns Hopkins Bloomberg School of Public Health. Erin also obtained a Master of Public Health (MPH) degree in Public Health from The George Washington University School of Hygiene and Public Health. Furthermore, Erin Sullivan holds a Bachelor of Science (BS) degree in Psychology from Vanderbilt University.